LOADING
Comparing Eli Lilly and Company (LLY) and Johnson & Johnson (JNJ), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | LLY | JNJ |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | -- | $658.9B |
| P/E Ratio | -- | 31.5 |
| Forward P/E | -- | 23.3 |
| PEG Ratio | -- | 4.75 |
| EPS | -- | $8.69 |
| Revenue Growth (YoY) | -- | 6.6% |
| Profit Margin | -- | 21.5% |
| Return on Equity | -- | 25.7% |
| Dividend Yield | -- | 1.93% |
| Beta | -- | 0.23 |
| 52-Week High | -- | $276.47 |
| 52-Week Low | -- | $170.33 |
| Volume | -- | -- |